ArticleKorean journal of ophthalmology : KJO2017

Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience.

Abdullah Ozkaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.